{"DataElement":{"publicId":"7058616","version":"1","preferredName":"Laboratory Procedure Creatinine Clearance Clinical Trial Eligibility Criteria Code Indicator","preferredDefinition":"The coded yes/no/not applicable indicator related to a creatinine laboratory procedure.","longName":"LAB_CREAT_CLR_CD_IND","context":"Theradex","contextVersion":"1","DataElementConcept":{"publicId":"7058614","version":"1","preferredName":"Laboratory Procedure Creatinine Clearance Outcome Clinical Trial Eligibility Criteria","preferredDefinition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting._The determination of the clearance of endogenous creatinine, used for evaluating the glomerular filtration rate._The result of an action._Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"2543047v1.0:7058612v1.0","context":"Theradex","contextVersion":"1","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7058612","version":"1","preferredName":"Creatinine Clearance Outcome Clinical Trial Eligibility Criteria","preferredDefinition":"The determination of the clearance of endogenous creatinine, used for evaluating the glomerular filtration rate.:The result of an action.:Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","longName":"C25747:C20200:C16112","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Creatinine Clearance","conceptCode":"C25747","definition":"The determination of the clearance of endogenous creatinine, used for evaluating the glomerular filtration rate.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Clinical Trial Eligibility Criteria","conceptCode":"C16112","definition":"Characteristics which are necessary to allow a subject to participate in a clinical study, as outlined in the study protocol. The concept covers inclusion and exclusion criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"97451AE9-FA0F-17B4-E053-F662850AB615","latestVersionIndicator":"Yes","beginDate":"2019-11-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-14","modifiedBy":"ONEDATA","dateModified":"2019-11-14","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008557","version":"1","preferredName":"Lab Results","preferredDefinition":"the results of laboratory tests.","longName":"LAB_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2CFBA7D-D009-7227-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"97451AE9-FA20-17B4-E053-F662850AB615","latestVersionIndicator":"Yes","beginDate":"2019-11-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-14","modifiedBy":"SOKKERL","dateModified":"2020-02-18","changeDescription":"11/14/19 ls","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3298541","version":"1","preferredName":"Yes No Not Applicable Code Indicator","preferredDefinition":"Indicator to represent a response of Yes, No, or Not Applicable._The affirmative response to a question or activity._The non-affirmative response to a question._Determination that a value is not relevant in the current context._A system of numbered categories for representation of data.","longName":"YES_NO_NA_CD_IND","context":"CCR","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"1","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"X","valueDescription":"Not applicable","ValueMeaning":{"publicId":"2581003","version":"1","preferredName":"Not applicable","longName":"2581003v1.00","preferredDefinition":"Determination of a value is not relevant in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0978-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-12-31","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-12-31","modifiedBy":"CLOHNES","dateModified":"2023-11-09","changeDescription":null,"administrativeNotes":"2023.3.6 Added Alt VM-COG. ak","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B04AC04D-C223-0627-E040-BB89AD432C31","beginDate":"2002-02-11","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","deletedIndicator":"No"},{"value":"N","valueDescription":"No","ValueMeaning":{"publicId":"2559515","version":"1","preferredName":"No","longName":"2559515","preferredDefinition":"The non-affirmative response to a question.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B588-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-02","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B04AC04D-C22D-0627-E040-BB89AD432C31","beginDate":"2002-08-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","deletedIndicator":"No"},{"value":"Y","valueDescription":"Yes","ValueMeaning":{"publicId":"2560453","version":"1","preferredName":"Yes","longName":"2560453","preferredDefinition":"The affirmative response to a question or activity.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B932-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CLOHNES","dateModified":"2023-09-26","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"B04AC04D-C237-0627-E040-BB89AD432C31","beginDate":"2002-08-22","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3298540","version":"1","preferredName":"Yes No Not Applicable Code Indicator","preferredDefinition":"The affirmative response to a question or activity.:The non-affirmative response to a question.:Determination that a value is not relevant in the current context.:A system of numbered categories for representation of data.:An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","longName":"3298540v1.0","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Yes","conceptCode":"C49488","definition":"The affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"4"},{"longName":"No","conceptCode":"C49487","definition":"The non-affirmative response to a question.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Not Applicable","conceptCode":"C48660","definition":"Determination of a value is not relevant in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Code","conceptCode":"C25162","definition":"A symbol or combination of symbols which is assigned to the members of a collection.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Indicator","conceptCode":"C25180","definition":"An event, entity or condition that typically characterizes a prescribed environment or situation and determines or aids in determining whether certain stated circumstances exist or criteria are satisfied.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B04AC04D-C1F2-0627-E040-BB89AD432C31","latestVersionIndicator":"Yes","beginDate":"2011-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"ONEDATA","dateModified":"2011-10-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTMS:Clinical Trials Monitoring Service","workflowStatus":"RELEASED","registrationStatus":"Application","id":"B04AC04D-C203-0627-E040-BB89AD432C31","latestVersionIndicator":"Yes","beginDate":"2011-10-27","endDate":null,"createdBy":"REEVESD","dateCreated":"2011-10-27","modifiedBy":"MAESKEB","dateModified":"2016-01-20","changeDescription":"Created to support Theradex design of CRFs for NCI CCR trials","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"3876352","version":"1","longName":"Inclusion Criteria","context":"Theradex","ClassificationSchemeItems":[{"publicId":"3876425","version":"1","longName":"Laboratory Data (including serologic/viral status)","context":"Theradex"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Is pre-study creatinine clear","type":"Preferred Question Text","description":"Is pre-study creatinine clearance greater than 30 ml/min?","url":null,"context":"Theradex"},{"name":"Theradex - 1","type":"Alternate Question Text","description":"Is serum creatinine less than or equal to the upper limit of normal or is pre-study glomerular filtration rate (GFR) greater than or equal to 60 mL/min/1.73m^2 (for patients with creatinine levels above the institutional normal)?","url":null,"context":"Theradex"},{"name":"Theradex - 2","type":"Alternate Question Text","description":"Is pre-study creatinine less than or equal to 1.5X institutional upper limit of normal OR creatinine clearance greater than or equal to 60 mL/min/1.73 m2 for patients with creatinine levels above 1.5X institutional normal, within 8 days of enrollment?","url":null,"context":"Theradex"},{"name":"Theradex - 3","type":"Alternate Question Text","description":"Is pre-study creatinine less than or equal to 1.5 mg/dL AND is glomerular filtration rate (GFR) greater than or equal to 60 mL/min/1.73 m2?","url":null,"context":"Theradex"},{"name":"Theradex - 4","type":"Alternate Question Text","description":"If patient is greater than or equal to 18 years old is creatinine clearance greater than or equal to 30 mL/min/1.73 m2 by Cockroft-Gault; if patient is less than 18 years old (pediatric patient) does serum creatinine based on age and gender meet the criteria in the table in section 3.1.7?","url":null,"context":"Theradex"},{"name":"Theradex - 5","type":"Alternate Question Text","description":"If patient is greater than or equal to 18 years of age, is creatinine clearance greater than or equal to 30 mL/min/1.73 m2 by Cockroft-Gault; if patient is less than 18 years of age (pediatric patient) does serum creatinine based on age and gender meet the criteria in the table in section 3.1.7?","url":null,"context":"Theradex"},{"name":"Theradex - 6","type":"Alternate Question Text","description":"Is pre-study serum creatinine less than or equal to 1.5 x institutional ULN OR glomerular filtration rate (GFR) greater than or equal to 60 mL/min/1.73 m2, unless data exists supporting safe use at lower kidney function values, no lower than 30 mL/min/1.73 m2?","url":null,"context":"Theradex"},{"name":"Theradex - 7","type":"Alternate Question Text","description":"Is pre-study creatinine clearance greater than or equal to 40 mL/min OR glomerular filtration rate (GFR) greater than or equal to 60 mL/min/1.73 m2 unless data exists supporting safe use at lower kidney function values, no lower than 30 mL/min/1.73 m2?","url":null,"context":"Theradex"},{"name":"Theradex - 10","type":"Alternate Question Text","description":"Is pre-study creatinine or measured or calculated or calculated creatinine clearance (CrCl) less than 1.5 × institutional ULN OR glomerular filtration rate (GFR) greater than 60 mL/min/1.73 m2?","url":null,"context":"Theradex"},{"name":"Theradex - 8","type":"Alternate Question Text","description":"Is pre-study total bilirubin less than or equal to 1.5 × institutional upper limit of normal (ULN) except for subjects with Gilbert's syndrome or genetic equivalent?","url":null,"context":"Theradex"},{"name":"Theradex - 9","type":"Alternate Question Text","description":"Is pre-study creatinine less than 1.5 × institutional ULN OR glomerular filtration rate (GFR) greater than or equal to 40 mL/min/1.73 m2?","url":null,"context":"Theradex"},{"name":"Theradex - 11","type":"Alternate Question Text","description":"Is pre-study creatinine less than or equal to 1.5 mg/dL OR is calculated creatinine clearance (Cockcroft-Gault formula) greater than or equal to 50 mL/min?","url":null,"context":"Theradex"},{"name":"Theradex - 12","type":"Alternate Question Text","description":"Is glomerular filtration rate (GFR) greater than or equal to 60 mL/min/1.73 m2 unless data exists supporting safe use at lower kidney function values, no lower than 30 mL/min/1.73 m2?","url":null,"context":"Theradex"},{"name":"Theradex - 13","type":"Alternate Question Text","description":"Is pre-study creatinine clearance greater than 45 ml/min?","url":null,"context":"Theradex"},{"name":"Theradex - 15","type":"Alternate Question Text","description":"Is pre-study calculated creatinine clearance greater than or equal to 30 mL/min.?","url":null,"context":"Theradex"},{"name":"Theradex - 14","type":"Alternate Question Text","description":"Is pre-study serum creatinine less than or equal to 1.5x upper limit of normal (ULN) OR creatinine clearance greater than or equal to 50mL/min according to Cockcroft Gault formula or other institutional methods?","url":null,"context":"Theradex"},{"name":"Theradex - 17","type":"Alternate Question Text","description":"Is pre-study measured or calculated creatinine clearance greater than or equal to 30 ml/min (GFR can also be used in place of creatine clearance (CrCl)), within 14 days prior to treatment?","url":null,"context":"Theradex"},{"name":"Theradex - 16","type":"Alternate Question Text","description":"Is pre-study creatinine clearance (CrCl) greater than or equal to 60 mL/min (using the CKD-EPI formula)?","url":null,"context":"Theradex"},{"name":"Theradex - 18","type":"Alternate Question Text","description":"Is measured creatinine clearance greater than or equal to 60 mL/min OR glomerular filtration rate (GFR) greater than or equal to 50 mL/min/1.73 m2?","url":null,"context":"Theradex"},{"name":"Theradex - 19","type":"Alternate Question Text","description":"Is pre-study creatinine clearance greater than or equal to 40 mL/min OR glomerular filtration rate (GFR) greater than or equal to 40 mL/min/1.73 m2 unless data exists supporting safe use at lower kidney function values, no lower than 30 mL/min/1.73 m2?","url":null,"context":"Theradex"},{"name":"Theradex - 20","type":"Alternate Question Text","description":"Is measured creatinine clearance within 2 weeks of enrollment greater than 60 mL/min/1.73 m2?","url":null,"context":"Theradex"},{"name":"Theradex - 21","type":"Alternate Question Text","description":"Is pre-study Cockcroft calculated creatinine clearance greater than or equal to 60 mL/min OR is glomerular filtration rate (GFR) greater than or equal to 60 mL/min/1.73 m2 unless data exists supporting safe use at lower kidney function values, no lower than 30 mL/min/1.73 m2?","url":null,"context":"Theradex"},{"name":"Theradex - 22","type":"Alternate Question Text","description":"Is pre-study serum creatinine less than or equal to 1.5x institutional ULN OR creatinine clearance greater than or equal to 30 mL/min by Cockcroft-Gault OR glomerular filtration rate (GFR) greater than or equal to 30 mL/min/1.73 m2 given this is a cisplatin-ineligible patient population) within 14 days prior to study registration?","url":null,"context":"Theradex"},{"name":"Theradex - 23","type":"Alternate Question Text","description":"Is pre-study creatinine clearance greater than 50 mL/min OR glomerular filtration rate (GFR) greater than or equal to 60 mL/min/1.73 m2?","url":null,"context":"Theradex"},{"name":"Theradex - 24","type":"Alternate Question Text","description":"Is pre-study creatinine less than or equal to 1.5 mg/dL AND is glomerular filtration rate (GFR) greater than or equal to 50 mL/min/1.73 m2?","url":null,"context":"Theradex"},{"name":"Theradex - 25","type":"Alternate Question Text","description":"Is pre-study creatinine\tless than or equal to 1.5 x institutional ULN OR glomerular filtration rate (GFR) is greater than or equal to 30 mL/min/1.73 m2 (by CKD-EPI)?","url":null,"context":"Theradex"},{"name":"Theradex - 26","type":"Alternate Question Text","description":"Is pre study creatinine less than or equal to 1.5 x institutional ULN OR is glomerular filtration rate (GFR) greater than or equal to 50 ml/min (based on the calculated CKD-EPI glomerular filtration rate estimation)?","url":null,"context":"Theradex"},{"name":"Theradex - 27","type":"Alternate Question Text","description":"Is pre-study creatinine clearance greater than or equal to 60 mL/min?","url":null,"context":"Theradex"},{"name":"Theradex - 28","type":"Alternate Question Text","description":"Is pre-study creatinine clearance greater than 30 mL/min based on the Cockroft-Gault glomerular filtration rate (GFR) estimation?","url":null,"context":"Theradex"},{"name":"Theradex - 29","type":"Alternate Question Text","description":"Is pre-study creatinine less than or equal to institutional ULN?","url":null,"context":"Theradex"},{"name":"Theradex - 30","type":"Alternate Question Text","description":"Is pre-study creatinine clearance greater than or equal to 30 mL/min/1.73 m2 by Cockcroft-Gault formula?","url":null,"context":"Theradex"},{"name":"Theradex - 31","type":"Alternate Question Text","description":"Is pre-study measured creatinine clearance greater than 60 mL/min OR glomerular filtration rate (GFR) greater than or equal to 60 mL/min/1.73 m2?","url":null,"context":"Theradex"}],"origin":"THERADEX:Theradex Systems Inc","workflowStatus":"RELEASED","registrationStatus":"Application","id":"975045B7-7AE4-117E-E053-F662850A06CC","latestVersionIndicator":"Yes","beginDate":"2019-11-14","endDate":null,"createdBy":"SOKKERL","dateCreated":"2019-11-14","modifiedBy":"SOKKERL","dateModified":"2023-10-31","changeDescription":"2020-8-3 AQT added for P10398. AK  11/14/19 ls","administrativeNotes":"7/21/2022: fixed the box symbol in AQT.wz","unresolvedIssues":null,"deletedIndicator":"No"}}